Charles Giancarlo, a director and officer of Everpure, Inc., filed a Form 144 notice of proposed sale on November 10, 2026, covering 70,000 shares of Everpure common stock with an aggregate market value of $7,198,800.00.

Key Highlights

  • Proposed sale: 70,000 shares of Everpure, Inc. common stock, with an aggregate market value of $7,198,800.00, are proposed to be sold on or around November 10, 2026.
  • Seller: Charles Giancarlo, identified in the filing as both a director and an officer of Everpure, Inc.
  • Source of shares: The shares were acquired through restricted stock units from the issuer, with the filing noting acquisition and payment dates of June 20, 2019; the filing states the securities "were acquired upon the vesting of restricted stock units during the period of 06/20/2019 through 12/20/2019."
  • Shares outstanding: 333,227,251 shares of common stock outstanding, according to the filing.
  • Prior 10b5-1 sales: The filing discloses two sales in the prior three months under a 10b5-1 plan: 70,000 shares sold on October 12, 2026 for gross proceeds of $10,761,352.00, and 70,000 shares sold on September 10, 2026 for gross proceeds of $6,657,819.00.
  • 10b5-1 plan date: The plan was adopted on September 26, 2025, according to the filing.
  • Exchange: NYSE, with the sale to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services.

Everpure Director and Officer Charles Giancarlo Files Notice of Proposed Common Stock Sale

According to the Form 144 filed with the U.S. Securities and Exchange Commission on November 10, 2026, Charles Giancarlo, who holds the dual role of director and officer at Everpure, Inc. (NYSE), intends to sell 70,000 shares of the company's common stock. The aggregate market value of the proposed sale is listed as $7,198,800.00. The designated broker for the transaction is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

The filing discloses that the shares proposed for sale were originally acquired through restricted stock units granted by the issuer. The filing states the securities "were acquired upon the vesting of restricted stock units during the period of 06/20/2019 through 12/20/2019," with the acquisition transaction dated June 20, 2019, and payment described as "N/A." The total amount of securities acquired in that transaction is listed as 70,000.

The filing also reports two prior sales by Giancarlo under a 10b5-1 plan during the three months preceding this notice: 70,000 shares sold on October 12, 2026, generating gross proceeds of $10,761,352.00, and 70,000 shares sold on September 10, 2026, generating gross proceeds of $6,657,819.00. The 10b5-1 plan underlying these transactions was adopted on September 26, 2025, according to the filing. By signing the notice, Giancarlo represented that he does not know any material adverse information regarding the issuer's current and prospective operations that has not been publicly disclosed.

What Was Disclosed

Everpure, Inc. director and officer Charles Giancarlo filed a Form 144 on November 10, 2026, proposing the sale of 70,000 shares of common stock valued at $7,198,800.00, with shares originating from restricted stock units vested between June and December 2019.